What is the recommended milliliter volume of crystalloid coload for spinal anesthesia in a healthy 70‑kg parturient undergoing cesarean section?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Crystalloid Coload Volume for Spinal Anesthesia in Cesarean Section

For a healthy 70-kg parturient undergoing elective cesarean section with spinal anesthesia, administer 700-1000 mL of crystalloid as a coload (10-15 mL/kg), initiated immediately after intrathecal injection, combined with prophylactic vasopressor infusion.

Evidence-Based Rationale

The 2016 ASA Practice Guidelines for Obstetric Anesthesia explicitly state that IV fluid preloading or coloading may be used to reduce the frequency of maternal hypotension after spinal anesthesia for cesarean delivery, but critically note that you should not delay the initiation of spinal anesthesia to administer a fixed volume of IV fluid 1. This establishes coloading (fluid given simultaneously with or immediately after spinal injection) as the preferred timing strategy over preloading.

Specific Volume Recommendations

The most recent high-quality research demonstrates a clear dose-response relationship:

  • 10 mL/kg crystalloid coload (700 mL for a 70-kg patient) reduces the required prophylactic norepinephrine dose by approximately 25% compared to no fluid 2
  • 5 mL/kg crystalloid coload reduces norepinephrine requirements by only 11.9% 2
  • The ED90 of prophylactic norepinephrine was 0.063 μg/kg/min with 10 mL/kg crystalloid versus 0.084 μg/kg/min with no fluid 2

Multiple studies using 1000 mL crystalloid coload (approximately 14 mL/kg for a 70-kg patient) have demonstrated effective hemodynamic support when combined with vasopressor prophylaxis 3, 4.

Practical Implementation Algorithm

Step 1: Fluid Selection

  • Use balanced crystalloid solutions (lactated Ringer's or Plasma-Lyte) rather than normal saline 5
  • Normal saline carries risks of hyperchloremic metabolic acidosis and renal vasoconstriction

Step 2: Timing and Administration

  • Begin infusion immediately after intrathecal injection (coload technique)
  • Administer rapidly using a pressure bag or rapid infuser
  • Complete the infusion within 10-15 minutes

Step 3: Concurrent Vasopressor Strategy

  • Initiate prophylactic phenylephrine or norepinephrine infusion simultaneously 1
  • Phenylephrine is preferred in the absence of maternal bradycardia due to improved fetal acid-base status 1
  • The fluid coload reduces but does not eliminate the need for vasopressor support

Colloid Considerations

Do not routinely add colloid to your fluid strategy. Recent evidence shows:

  • 500 mL colloid preload + 500 mL crystalloid coload provides no advantage over 1000 mL crystalloid coload alone in terms of ephedrine requirements, hypotension incidence, or neonatal outcomes 3
  • Colloid coloading (6% hydroxyethyl starch 10 mL/kg) does not reduce the ED90 of prophylactic norepinephrine compared to crystalloid 6
  • While colloid preloading transiently increases cardiac output before spinal anesthesia, this effect is not sustained after the block 4

The 2020 systematic review on viscoelastic testing notes that 500 mL hydroxyethyl starch produces mild coagulation effects, though values remain within normal range 7. Given the lack of clinical benefit and potential coagulation concerns, crystalloid alone is preferred.

Critical Caveats

Volume Overload Risk: Pregnant patients have lower colloid oncotic pressure and higher risk of pulmonary edema 5. The 2025 SMFM maternal sepsis guidelines recommend tailoring fluid volumes to patient condition, though this applies to septic patients 5. For healthy parturients, 10-15 mL/kg crystalloid is safe when administered over 10-15 minutes.

Avoid Excessive Fluid: The antidiuretic effect of oxytocin (both endogenous and infused) increases fluid retention risk 8. Do not exceed 15 mL/kg as initial coload without specific indication.

Monitor for Hypotension Despite Fluid: Crystalloid coload reduces but does not eliminate hypotension. Have rescue vasopressor boluses immediately available (phenylephrine 50-100 mcg or ephedrine 5-10 mg) 1.

Adjust for Patient Size: The volume of distribution is proportionate to body habitus 8. For patients significantly smaller or larger than 70 kg, calculate based on actual body weight (10-15 mL/kg), not a fixed volume.

References

Guideline

maternal sepsis review and update.

Mayo Clinic Proceedings, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.